U.S. Water Utilities Stock News

Event driven spotlight on Genuine Parts stock Genuine Parts (GPC) has moved back onto investor radars after its annual shareholder meeting, where the company outlined plans to separate its automotive and industrial businesses into two independent, publicly traded companies. This planned split, paired with a higher 2026 dividend and reaffirmed guidance, provides a fresh set of milestones to monitor when comparing Genuine Parts stock with your income and total return goals. See our latest...

In the first quarter of 2026, Chipotle Mexican Grill reported revenue of US$3,088.24 million, up from US$2,875.25 million a year earlier, while net income fell to US$302.82 million and the company continued expanding with plans for 350 to 370 new restaurant openings this year. Alongside fresh leadership appointments in brand and digital, Chipotle ramped up menu innovation with the return of its ChipotleHoney Chicken, enhanced its loyalty program, expanded technology pilots like...

In recent weeks, Hewlett Packard Enterprise has reported strong Q1 FY2026 results, lifted its full-year outlook, and highlighted surging AI infrastructure demand and networking growth following the Juniper integration. At the same time, HPE has expanded its ProLiant edge portfolio with rugged, AI-ready servers and new security offerings, underscoring a push into mission-critical, distributed environments where reliability and governance are central. Next, we’ll explore how this combination...

In recent weeks, Arrow Electronics has attracted attention as earnings estimates edged higher and research firm Zacks assigned the stock a Rank #2 (Buy) with a Momentum Style Score of B, alongside new SEC filings showing Vanguard entities holding passive stakes above 5% of outstanding shares as of March 31, 2026. This combination of incremental earnings upgrades, favorable momentum indicators, and sizeable passive institutional ownership highlights shifting sentiment toward Arrow’s...

IDEAYA Biosciences recently announced that the FDA has agreed to review its New Drug Application for darovasertib combined with crizotinib in first-line HLA*A2-negative metastatic uveal melanoma under the Oncology Center of Excellence Real-Time Oncology Review program, following positive Phase 2/3 OptimUM-02 trial results that met the study’s primary endpoint. This regulatory milestone highlights darovasertib’s potential to address a genetically defined segment of a rare eye cancer with...

In late April 2026, Klaviyo launched Custom Skills for its Customer Agent, allowing brands to extend the AI agent beyond standard order tracking, returns, and product recommendations by defining plain‑language logic and connecting to any system in their tech stack. This update lets businesses tailor AI‑driven customer service to their specific policies and workflows, creating experiences that align more closely with their individual brand models and CRM data. We’ll now examine how this new...

In recent weeks, FuelCell Energy unveiled a standardized 12.5 MW “Power Block” aimed at AI and cloud data centers and outlined plans to more than triple its Connecticut manufacturing capacity to serve a rapidly expanding pipeline that is now heavily weighted toward digital infrastructure projects. This shift toward modular, on-site data center power marks a meaningful evolution in how FuelCell Energy positions its fuel cell technology within the broader race to secure reliable electricity...

In the first quarter of 2026, nVent Electric plc reported record sales of US$1,242 million, up from US$809.3 million a year earlier, with earnings per share from continuing operations rising despite total net income being lower than the prior year. The results were powered by surging data center and infrastructure demand, prompting nVent to raise its full-year sales and earnings guidance while ramping capacity, including a new Blaine, Minnesota facility. We’ll now examine how this guidance...

In late April and early May 2026, Neurocrine Biosciences reported new two-year Phase 3 CAHtalyst data showing that CRENESSITY (crinecerfont) provided durable androgen control and allowed sustained reductions in glucocorticoid dosing in both adult and pediatric patients with classic congenital adrenal hyperplasia. The extended data also linked CRENESSITY use to clinically meaningful improvements in outcomes tied to excess androgens and long-term steroid exposure, strengthening its profile as...

In late April 2026, Merit Medical Systems reported first-quarter 2026 results showing US$381.88 million in sales and US$41 million in net income, with both basic and diluted earnings per share from continuing operations rising versus a year earlier and adjusted earnings and margins coming in ahead of analyst expectations. At the same time, the company slightly raised its full-year 2026 revenue guidance to about US$1.62 billion and expanded its oncology platform through the Viewpoint Medical...

In the first quarter of 2026, Proto Labs, Inc. reported revenue of US$139.34 million and net income of US$8.11 million, with diluted earnings per share from continuing operations of US$0.33, all higher than a year earlier. The company paired these record quarterly results with guidance calling for 6% to 8% revenue growth in 2026 and stronger second-quarter earnings, underscoring how its transformation efforts and demand for CNC machining are influencing its financial profile. We’ll now...

The Pennant Group, Inc. recently assumed operations of three assisted living communities in Arizona and Wisconsin, adding 194 senior living units under new local brands Saguaro Assisted Living, Cardinal Lane Senior Living, and Harbor Haven Senior Living. This cluster-style expansion across key regional markets under triple net leases reinforces Pennant’s focus on scaling its senior living platform while emphasizing continuity of care for residents. Next, we’ll examine how assuming 194...

In April 2026, LGI Homes, Inc. reported first‑quarter net income of US$2.16 million, down from US$3.99 million a year earlier, with basic and diluted earnings per share from continuing operations easing to US$0.09 from US$0.17. A week earlier, the company launched Citrus Place in Central Florida’s Polk County, showcasing its focus on larger lots, packaged finishes, and amenity‑rich, entry‑level communities starting in the high‑US$200,000s. With earnings softer than a year ago, we’ll now...

MSA Safety’s latest dividend move and firefighter product update MSA Safety (MSA) has drawn fresh attention after its board approved a higher quarterly common dividend and declared a preferred dividend, alongside updates to its firefighter breathing apparatus and connected safety tools. See our latest analysis for MSA Safety. At a share price of $165.79, MSA Safety has seen a 2.2% year to date share price return and a 7.8% total shareholder return over the past year, with recent gains...

Avantor (AVTR) is in the spotlight after its CFO departure, recent CEO change and the ongoing Revival turnaround program, as the company reports flat year-on-year quarterly sales and keeps forward guidance intact. See our latest analysis for Avantor. Avantor's share price has weakened over time, with a 90 day share price return of 26.64% and a 1 year total shareholder return of 36.98%. This suggests sentiment has softened even as management pushes the Revival program and leadership...

Spyre Therapeutics (SYRE) recently closed an underwritten public offering that raised about US$463.5 million. This provides the company with additional capital to fund its inflammatory and rheumatic disease programs and has drawn fresh attention from Wall Street coverage. See our latest analysis for Spyre Therapeutics. The stock has been volatile around these announcements, with a 1-day share price return decline of 6.76% and a 7-day share price return decline of 3.45%. However, a 30-day...

Why Yum! Brands (YUM) is on investors’ radar today Yum! Brands (YUM) is drawing attention after recent trading left the stock with a one-month return of 1.45% and a past three-month move of 0.24%, alongside reported annual revenue of US$8.49b and net income of US$1.74b. See our latest analysis for Yum! Brands. At a share price of US$158.36, Yum! Brands has recently seen a 2.06% 7 day share price return and a 5.23% year to date share price return, while the 1 year total shareholder return...

Impinj (PI) drew fresh attention after first quarter 2026 results showed revenue of US$74.25 million, record endpoint IC bookings, and guidance for second quarter revenue and net income that was well above earlier consensus forecasts. See our latest analysis for Impinj. The strong second quarter guidance and record endpoint IC bookings have coincided with a sharp swing in sentiment, with the 30 day share price return of 46.55% and 7 day share price return of 20.55% reversing the negative year...

Why the new Team USA program matters for PennyMac Mortgage Investment Trust (PMT) PennyMac Mortgage Investment Trust (PMT) is in focus after launching the Welcome Home: Athlete Mortgage Program with PennyMac Financial Services. The program targets Team USA athletes with tailored lending support, benefits, and education. See our latest analysis for PennyMac Mortgage Investment Trust. The Athlete Mortgage Program arrives as PMT’s share price trades at US$12.33, with a 30 day share price return...

In recent days, Repligen Corporation prepared to report its Q1 earnings, with the market expecting revenue to grow 13.3% year-on-year and analysts largely reiterating estimates for the period. This steady analyst confidence in projected revenue acceleration, despite previous insider selling and valuation concerns, highlights how closely investors are watching the company’s execution heading into earnings. Next, we’ll examine how expectations for faster Q1 revenue growth could influence...

Relay Therapeutics recently reported encouraging Phase 1/2 data for its lead asset zovegalisib in heavily pre-treated PI3Ka‑mutated HR+/HER2- metastatic breast cancer and outlined plans, subject to regulatory feedback, to launch a Phase 3 trial in collaboration with Pfizer’s investigational CDK4 inhibitor atirmociclib. At the same time, Relay is seeking shareholder approval to increase its authorized common stock pool and is seeing strong interest from Wall Street analysts, underscoring how...

Cousins Properties reported first-quarter 2026 results on April 29, 2026, with revenue rising to US$263.11 million while moving from net income of US$20.9 million a year earlier to a net loss of US$24.86 million, largely due to a US$36.6 million impairment on its One Eleven Congress asset. Despite the accounting loss, the company showed resilient operations with strong Sun Belt leasing activity, higher occupancy, an increase in funds from operations guidance, and an expanded US$500 million...

ServiceNow (NOW) is back in focus after first quarter results showed US$3.77b in revenue and raised full year subscription guidance, supported by expanding AI workflows, new healthcare partnerships, and a deeper collaboration with Google Cloud. See our latest analysis for ServiceNow. Despite the strong Q1 update and new AI and healthcare partnerships, sentiment around enterprise software has been volatile. ServiceNow’s 1 month share price return of 10.63% and year to date share price return...

In late April 2026, Tenet Healthcare reported first-quarter 2026 results with net operating revenues of about US$5.37 billion and net income of US$702 million, comfortably ahead of the prior year, and issued full-year 2026 guidance calling for net operating revenues of US$21.50 billion to US$22.30 billion and net income of US$2.61 billion to US$2.84 billion. Management highlighted that expense controls, higher-acuity procedures in its ambulatory surgery centers, and AI-driven efficiency...